Alex Temple

🚀 Introducing Unlimited Job Postings from BioJobs Lab! 🚀 Are you ready to turbocharge your hiring process? BioJobs Lab is thrilled to introduce our Unlimited Job Postings package! With our Unlimited Job Postings package, you can post as many job openings as you need without any limitations. Whether you're hiring research scientists, clinical trial managers, or biotech executives, our platform has you covered. Why Choose BioJobs Lab for Your Hiring Needs? 🔍 Access to Top Talent: Our platform attracts a diverse pool of professionals with expertise in the biotechnology industry. 💼 Streamlined Recruitment Process: Easily manage and track your job postings from start to finish with our user-friendly dashboard. 📈 Cost-Effective Solution: Say goodbye to per-posting fees and maximize your recruitment budget with our unlimited package. 💡 Expert Support: Our team of dedicated recruiters is here to support you every step of the way, from crafting job descriptions to sourcing top candidates. Get Started Today! Ready to revolutionize your hiring strategy? Visit our website to learn more about our Unlimited Job Postings package and start posting your openings today: www.biojobslab.com/pricing Let BioJobs Lab help you find the talent you need to drive your organization forward! #BioJobsLab #JobPostings #Hiring #BiotechJobs #Recruitment #HR #TalentAcquisition #Biotechnology #LifeSciences #JobSearch #EmploymentOpportunities

1

Are you interested in joining Myriad Genetics?🧬 Watch this video to see a step-by-step tutorial on how to view all of our open requisitions and how to apply at Myriad.com. #openpositions #genetictesting #genetics #recruitment #precisionmedicine #applynow

60

3 Comments

This is the hiring process for a Director of Computational Biology of a VC-backed 'Omics company in Boston: 👇 [1] 30 - 45 min prescreening call with Moxee [2] 30-minute meeting with HR and Talent Acquisition [3] 45-min Meeting with VP of Computational Biology [4] 45-min Meeting with the CTO [5] 3-hour Online Analysis and Method Development Challenge [6] Panel Interview, Onsite - 14 people involved [7] Hiring The problems are: [1] 73% of applicants failed the challenge. [2] Those who did fail weren't receiving feedback as to why = damaged candidate experience within an already small candidate pool, after investing so much time and mental effort. [3] Far too long. [4] They are a remote-first business, so for the onsite panel interview, it's going to take a loooooot of time / financial commitment. [5] The process didn't outline expectations or criteria for success at each stage, leaving candidates uncertain about what is being assessed and how to prepare. [6] There wasn't one single female interviewee (besides HR). [7] The criteria for final hiring decisions, including the weight assigned to each stage of the interview process, were not considered. We're now doing this, with the process clearly stated upfront: [1] 45-min interview with Moxee + HR, with video clips of 4 x predetermined questions shared with VP Comp Bio. ✅ [2] 1.5-hour live task (a typical problem they would solve within the first 6 months in the job role) with the VP of Comp Bio. ✅ [3] 1-hour talk with the CTO and CEO. ✅ [4] Talk with existing team of Comp Biologists. ✅ [5] Hiring. ✅ • Hours saved per candidate = 5 hours 30 mins • Freed up time of the CTO, CEO, and junior Computational Biologists • Reduced time-to-hire / increased sanity 🤣

43

7 Comments

Biotech job seekers need someone in their corner. This a snapshot of the last three people I found a new job: VP Quality - not originally selected for interview. QC Director - not originally selected for interview. QA Director - not originally selected for interview. I’ve spoken to so many senior level quality executives in the last year who have applied for a role via LinkedIn and not got a look-in. Many of these people are qualified for the role and would make great candidates, but their application goes into a ‘black-hole’. It’s incredibly competitive right now. If you haven’t got someone in your corner that understands the true value you can bring to an organisation, and can clearly communicate this to a potential hiring manager, your resume/CV might get overlooked. Work with your headhunter/recruiter to be crystal clear on what benefits your experience brings to a specific organisation.

65

5 Comments

Seeking Biotech Pioneers! In the fast-paced world of biotechnology, the right team isn't just an asset; it's the heartbeat of innovation. As a seasoned professional in the Clinical Operations sector, I understand the unique challenges you face in staffing projects that push the boundaries of science and medicine. Are you tirelessly searching for that perfect fit to drive your clinical trials forward? Look no further. My expertise lies in providing bespoke contract staffing solutions tailored to the dynamic needs of biotech firms across Europe. I bridge the gap between visionary companies and the top-tier talent they need to thrive. Here's what I bring to your table: - A robust network of pre-vetted clinical operations professionals - Swift turnaround times to keep your projects on track - A deep understanding of the biotech landscape and regulatory requirements - Flexible staffing models to suit your project scale and duration Whether you're a start-up on the verge of a breakthrough or an established firm scaling new heights, my goal is to empower your mission with the right people behind the science. Let's collaborate to build a future where health innovations reach those who need them most, faster and more efficiently. Drop a comment, send a message, or simply hit 'Like' if you're ready to elevate your clinical operations with the top talent in the industry. #BiotechTalent #ClinicalOperations #StaffingSolutions #Science #HRS

7

🚀 AI isn't the magic bullet to simplify drug discovery 💊 🔬 Wet-lab biology and translational models are key to confirming AI-derived findings 🔍 AI is a game-changer in pharma, but it’s not a silver bullet. 💡 Despite $60B+ investments since 2014, early high-profile clinical failures suggest we must refine the approach. Exscientia and BenevolentAI's recent setbacks highlight the challenge: AI can identify correlations, but it’s not enough. 🤔 Why? Because even the best datasets can’t fully digitize human biology. 📊 AI tools, while powerful, need validation through real biological samples and longitudinal studies. This is where Bayesian AI shines, offering hypothesis-free discovery and deeper insights into disease causation. 🧬 By leveraging real biological samples, AI can transcend the traditional try-and-fail approach, leading to faster novel discoveries and higher clinical trial success rates. 🌱 We’ve seen promising results in glioblastoma multiforme and pancreatic cancer through this integrated approach. 🧠 With robust wet-lab validation and preclinical models, AI can bring us closer to precision medicine. 🧪 Understanding the mechanisms of action and patient-specific responses will revolutionise clinical trials and therapeutic development. 📈 #Pharma #AI #DrugDiscovery #Biotech #ClinicalTrials #PrecisionMedicine #Innovation #Healthcare #BiologyFirst #BayesianAI

2

1 Comment

AI innovation is crafting intricate designs for microscopic biological processes capable of editing your DNA. Leveraging methodologies similar to those driving ChatGPT, this technology indicates a future where scientists combat illnesses and diseases with unprecedented precision. Fueling the development of novel gene editors, it draws from Nobel Prize-winning techniques centered around CRISPR, which are revolutionising scientific research and healthcare. CRISPR offers a transformative avenue for modifying genes associated with inherited disorders like sickle cell, anemia and blindness, reshaping how we approach these conditions. The advancements in AI and CRISPR technology are absolutely phenomenal It's incredible to see how these breakthroughs are revolutionising healthcare and scientific research. The potential for precision gene editing and its implications for treating genetic diseases like sickle cell, anemia and blindness are particularly fascinating. It makes you wonder what else is possible amongst AI and Robotics that are no longer confined to the realms of science fiction. 🤔 #AI #CRISPR #GeneticEditing #HealthcareRevolution https://lnkd.in/eBD-MyfJ

7

Enjoying the COG New England conference - meeting great people. #COG #COGNewEngland #ClinicalTrials #ClinicalResearch #ClinicalOutsourcing Most interesting Panel yesterday with biotech CEOs from Massachusetts who were cautiously optimistic about the life science investment environment. Some themes: ·       The power of big pharma money currently. ·      The inflection point for further investment has shifted further along the “get great data” timeline so you have to do more with your money. ·      A natural reset has occurred – cheap money from years gone by in a low interest rate environment is no longer around and investors are looking for value now. ·      Newer technologies including gene therapy may struggle as investors seek quicker value. ·      The need for cashing out and re-cycling. We need a wave of IPOs and exits to recycle investment cash. ·      A hope for a more positive investment environment as interest rates fall but caution given no-one knows what election season will bring! ·      Hot areas include: Obesity/Cardiobetes/ADCs/Radiotherapies/Neuro/Autoimmune   In all a very impressive bunch of CEOs and some cause for hope and a rising tide this year.

24

What’s your “why”? I get asked this question all the time during interviews. “Why” do you do what you do? “Why” Labcorp? Once I started doing what I do-working in Talent Acquisition and Recruitment, the “why” was easy. I have the ability to make an impact on people’s lives on a daily basis. In my current position, I am privileged to speak to students of all backgrounds, both personally and academically, about the company has to offer. To hear the excitement in their voices on Friday afternoons when I call to make them an offer, “you made my weekend” they often exclaim and to me that’s “why”. Often, when people ask the “why” about Labcorp, I let them know to buckle up for a story. 25 years ago, like all college age students, I knew exactly what I was going to do for the rest of my life. At the time, I was living in New Orleans working in the restaurant industry and making a name for myself and loving the work (not always the hours though). Fast forward millions and millions of steps (just an estimate in the pre-iPhone era) across tile kitchens and dining rooms and my body said that’s enough. I had my first hip surgery and knew it was time for a change. I became a recruiter and all the “why’s” above drove me. 7 years ago, I had an opportunity to leave the agency side of the business and jump into the healthcare space-mind you, I knew NOTHING of the space. What I found in this company were people, and they became my “why” Labcorp. Their’s was a passion that was unbridled about the work we were doing and continue to do. They were patient with me while they explained their teams, their jobs, their passion-it inspired me and still does. To see the impact our teams across all spaces around the globe make on a daily basis to providing a healthier life, it is my “why” Labcorp. If you want to hear more about my “why”-send me a note, shoot me a text, let’s connect and discuss! Even better-drop your “why” below. #impactlives #makeadifference #lovewhatyoudo #dowhatyoulove #recruiterstory #why

36

1 Comment

🙌 New Podcast Alert. 🚨 This week featuring ALCOA Consulting, LLC talking about the state of the job market in 2024 and all things clinical operations. Tune in now 👍 https://lnkd.in/e4hgQMxi

3

1 Comment

🔬 Calling All Biotech Companies: Showcase Your Opportunities with BioJobs Lab! 🌟 Are you a biotech company on the lookout for top talent to drive your innovation forward? Look no further than BioJobs Lab – your ultimate platform for connecting with skilled professionals in the biotech industry. 🚀 Why Choose BioJobs Lab for Your Hiring Needs? ➡️ Targeted Audience: BioJobs Lab attracts a diverse and highly qualified pool of candidates with expertise in biotechnology, life sciences, pharmaceuticals, and related fields. Reach the talent you need to propel your projects to new heights. ➡️ Visibility and Reach: With over 800 active job listings and a growing community of biotech professionals, BioJobs Lab offers unparalleled visibility and reach for your job postings. Get your opportunities in front of the right candidates – fast. ➡️ Personalized Support: Our experienced team is dedicated to providing personalized support every step of the way. From optimizing your job listings to offering strategic guidance, we're here to ensure your hiring success. ➡️ Innovation and Collaboration: Join a community of forward-thinking companies and industry leaders who are shaping the future of biotechnology. Tap into a network of like-minded innovators and foster collaboration for mutual growth. 🔍 How to Get Started: Posting your job opportunities on BioJobs Lab is quick and easy. Simply create an employer account, craft your job listings with our user-friendly tools, and start connecting with top talent today. Ready to take your hiring efforts to the next level? Join BioJobs Lab and unlock a world of possibilities in biotech talent acquisition. #BioJobsLab #BiotechCompanies #TalentAcquisition #CareerOpportunities #Biotechnology #LifeSciences #Innovation #HiringNow #EmployerBrand #Recruitment #JobPostings

2

📰 In Brief This Week 📰 -Bionano Genomics closes a $10M direct offering with potential for $20M more from milestone-linked warrants. Funds to be used for R&D, working capital, and more. 💰🔬 #Biotech #Funding #R&D -Thermo Fisher Scientific announces a quarterly dividend of $.39 per share, payable on Oct. 15, 2024. 📈💵 #Dividends #Investments #ThermoFisher -Helio Genomics completes separation from Laboratory for Advanced Medicine. Now an independent entity, Helio focuses on commercializing its liver cancer test, HelioLiver Dx. 🧬🩸 #CancerDiagnostics #Genomics -Volition Rx partners with PharmaVentures to outlicense its oncology portfolio, including Nu.Q Cancer assays and Capture-PCR detection method. 🤝🔍 #Oncology #StrategicPartnership #Biotech -Mainz Biomed submits next-gen colorectal cancer test for FDA breakthrough device designation. Assay shows 97% sensitivity for colorectal cancer. 📑🧫 #CancerScreening #FDA #Innovation - Parse Biosciences launches CSP program with SeqMatic and Eurofins Clinical Enterprise offering single-cell products as a service. 🌐🔬 #SingleCell #BiotechServices #ParseBiosciences -MGI Australia partners with University of Queensland's CEAStAR for antimicrobial resistance testing and surveillance using DNBSeq technology. 🌊🦠 #AMR #Collaboration #MGI #BiotechNews #HealthcareInnovation #LifeSciences #MedicalResearch #TechInMedicine #InnovationInHealthcare #ScientificBreakthroughs

6

1 Comment

🔬🌟 Biotechnology Jobs: Post Now Starting at $299 with BioJobs Lab! 🌟🔬 Looking to fill positions in the dynamic field of biotechnology? Look no further! BioJobs Lab is thrilled to announce our new pricing for Biotechnology job postings, starting at just $299! With our affordable pricing and specialized platform, you can connect with top talent in the biotech industry without breaking the bank. Whether you're hiring research scientists, laboratory technicians, or biotech engineers, our platform has you covered. Why Choose BioJobs Lab for Your Biotechnology Hiring Needs? 🔍 Targeted Audience: Our platform attracts a diverse pool of professionals with expertise in biotechnology, ensuring that your job postings reach the right candidates. 💼 Cost-Effective Solution: Say goodbye to expensive job postings! With our affordable pricing starting at $299, you can maximize your recruitment budget and find the talent you need. 📈 User-Friendly Platform: Easily manage and track your job postings with our intuitive dashboard. From posting to hiring, we've got you covered every step of the way. 💡 Expert Support: Our team of dedicated recruiters is here to assist you with crafting job descriptions, sourcing top candidates, and more. Get Started Today! Ready to find the perfect candidate for your biotechnology team? Visit our website to learn more about our affordable job posting options and start posting your openings today: https://lnkd.in/dM2PuXA4 Let BioJobs Lab help you find the talent you need to drive your biotechnology projects forward! #BioJobsLab #BiotechJobs #JobPostings #Hiring #Biotechnology #LifeSciences #Recruitment #HR #TalentAcquisition #JobSearch #EmploymentOpportunities

2

1 Comment

BioSpace recently published its 2024 Life Sciences Salary Report. Of note: ✔ Industry salaries continue to grow, though slower than 2020-2021. ✔ 2023 was economically challenging. ✔ Money is a top motivator for professionals to change jobs/companies. ✔ Employers are more selective when filling roles due to candidate availability and tight budgets. The report also highlights regional salary/bonus averages and U.S. averages by job title. Narrowing in on compensation related to geography, industry, company size, and years of experience can be a challenge for smaller organizations. Talencio assists our health technology clients in finding great talent and properly compensating that talent using national and regional salary survey data. Let us know if we can help! https://lnkd.in/eqemkMnM #compensationsurvey #talencio #salarybenchmark #lifesciences

5

1 Comment

🔬 Attention U.S. Biotech and Pharma Professionals: Major Industry Shifts on the Horizon? 🧪 The ongoing scrutiny of Chinese CDMOs, particularly WuXi AppTec, could reshape our industry landscape. Here's what you need to know: 1. The BIOSECURE Act, if passed, could force U.S. drugmakers to cut ties with certain Chinese biotech companies by 2032. This affects over 120 U.S. biopharma drugs currently partnered with these firms. 2. WuXi AppTec's deep integration in U.S. pharma (involved in developing ~25% of drugs used in the U.S.) means any restrictions could have far-reaching effects on drug development pipelines. 3. Indian CDMOs are positioning themselves to potentially fill the gap. With a market estimated at $22 billion and growing, they're ramping up investments in capacity and capabilities. 4. However, challenges remain. Indian CDMOs may face hurdles in small molecule production and need to address quality concerns. 5. We might see a push towards domestic U.S. CDMOs as concerns grow about offshore dependencies. As industry professionals, we need to stay ahead of these potential shifts. How is your organization preparing for possible changes in the CDMO landscape? #Biotech #Pharma #CDMO #DrugDevelopment #RegulatoryChanges

6

Let’s hope this is a big step forward by anticipating and addressing potential regulatory backlog given the inflection of #cellandgene therapy and #AI approaches. The logic being that a standardized framework for development platforms could take less assessment time and offer #biotech swifter approvals and reduced development costs. #innovation #medicine #pharmaceutical #

5

Congratulations to Rubedo Life Sciences, a biopharmaceutical company with a focus on age-related diseases that secured $40 million in Series A funding yesterday. The round was led by investors Khosla Ventures and Ahren Innovation Capital, with participation from Hevolution, R42, Modi Ventures, Cerigo Investments, and others. “Rubedo is targeting senescent, or aging, cells that drive age-related diseases. This first trial can bring us another step closer to achieving better healthspan.” #RubedoLifeSciences #biotech #biotechfunding #clinicalresearch #clinicalresearchupdates

6

I notice that many internal biotech recruiters aren’t always leveraging LinkedIn. (And honestly, I get it. I’ve seen your goals for this year. 🤣 🤗) A few weeks ago, I happily stumbled upon Sean Kennedy. He's the Principal Talent Acquisition Partner at BenchSci. If I were looking for roles in preclinical R&D and AI, I’d want to join them in a heartbeat. Sean doesn't try to be everything to everyone. Sean is a Dad, who cares deeply about the fact that health is absolute wealth in the workplace. He talks about this and how it aligns with BenchSci's perks, benefits, and priorities. I connect with Sean’s message because: 1) With an autoimmune disease, I’ve often felt like my health and career growth couldn’t coexist in the workplace. 2) As a woman, I’m a bit unsure about how I’ll balance parenthood and professional development without the right support. I'm therefore drawn to BenchSci. You don’t (always) have to chase talent. With the right tactics and a little more legwork, talent can be drawn to you. PS - follow Sean Kennedy & BenchSci if you haven't already! They're hiring for Product / ML / AI / Engineering roles. 💜 Several are remote.

37

8 Comments

In the wake of recent U.S. biotech layoffs, ripple effects cascade beyond the lab, impacting ancillary industries and local economies. Job losses reverberate, influencing supply chains and consumer spending, amplifying the economic downturn. Amidst this turbulence, innovation stagnates, potentially hindering breakthroughs in healthcare and research. As the lifeblood of biotech recedes, interconnected sectors face challenges, creating a domino effect with far-reaching consequences. Navigating these turbulent waters demands resilience and adaptability. Collaboration and diversification become key strategies for weathering the storm, fostering a sustainable ecosystem amidst uncertainty. Let's discuss: How can we cultivate resilience in the face of industry upheavals? Share your insights in the comments below. Your perspective matters. #BiotechIndustry #EconomicImpact #InnovationInCrisis

4